Título:	New perspectives on the topical management of recurrent candidiasis
Autor(es):	Ré, Ana Carolina S. Martins, Jayanaraian F. Cunha Filho, Marcílio Sérgio Soares da Gelfuso, Guilherme Martins Aires, Carolina P. Gratieri, Taís
Assunto:	Candidíase Reincidência Biofilme Tecnologia farmacêutica
Data de publicação:	19-Jan-2021
Editora:	Springer Nature
Referência:	RÉ, Ana Carolina S. et al. New perspectives on the topical management of recurrent candidiasis. Drug Delivery and Translational Research, n.11, p.1568-1585, 2021. DOI: https://doi.org/10.1007/s13346-021-00901-0.
Abstract:	Candidiasis is a common opportunistic infection caused by fungi of the Candida genus that affects mainly mucocutaneous tissues (e.g., vaginal, oral, and mammary). This condition has been known for a long time; thus, innumerous topical and systemic treatments are already available on the market worldwide. Yet, recurrent superficial candidiasis (RSC) is an expected outcome, still lacking effective and convenient treatments. Although several individual conditions may contribute to disease recurrence, biofilms’ presence seems to be the main etiological factor contributing to antifungal resistance. More than proposing novel antifungal agents, current research seems to be focusing on improving the pharmaceutical technology aspects of formulations to address such a challenge. These include extending and improving intimate contact of drug delivery systems with the mucocutaneous tissues, increasing drug loading dose, and enhancing topical drug permeation. This review discusses the current understanding of the RSC and the use of pharmaceutical technology tools in obtaining better results. Even though several drawbacks of conventional formulations have been circumvented with the help of nano- or microencapsulation techniques and with the use of mucoadhesive formulation excipients, many challenges remain. In particular, the need to mask the unpalatable taste of formulations for the treatment of oral candidiasis, and the necessity of formulations with a “dryer” sensorial feeling and improved performances in providing higher bioavailability for the treatment of mammary and vaginal candidiasis.
DOI:	https://doi.org/10.1007/s13346-021-00901-0
Versão da editora:	https://link.springer.com/article/10.1007%2Fs13346-021-00901-0
Aparece nas coleções:	Artigos publicados em periódicos e afins

Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.